GCTK
Price
$0.17
Change
-$0.01 (-5.56%)
Updated
May 2, 02:45 PM (EDT)
Capitalization
8.11M
IVRO
Price
$0.08
Change
-$0.01 (-11.11%)
Updated
May 1 closing price
Capitalization
911.82K
Ad is loading...

GCTK vs IVRO

Header iconGCTK vs IVRO Comparison
Open Charts GCTK vs IVROBanner chart's image
GlucoTrack
Price$0.17
Change-$0.01 (-5.56%)
Volume$300
Capitalization8.11M
InVitro International
Price$0.08
Change-$0.01 (-11.11%)
Volume$102.04K
Capitalization911.82K
GCTK vs IVRO Comparison Chart
Loading...
GCTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GCTK vs. IVRO commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTK is a StrongBuy and IVRO is a Hold.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (GCTK: $0.18 vs. IVRO: $0.08)
Brand notoriety: GCTK and IVRO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GCTK: 148% vs. IVRO: 969%
Market capitalization -- GCTK: $8.11M vs. IVRO: $911.82K
GCTK [@Medical Specialties] is valued at $8.11M. IVRO’s [@Medical Specialties] market capitalization is $911.82K. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GCTK’s FA Score shows that 0 FA rating(s) are green whileIVRO’s FA Score has 1 green FA rating(s).

  • GCTK’s FA Score: 0 green, 5 red.
  • IVRO’s FA Score: 1 green, 4 red.
According to our system of comparison, IVRO is a better buy in the long-term than GCTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GCTK’s TA Score shows that 3 TA indicator(s) are bullish.

  • GCTK’s TA Score: 3 bullish, 2 bearish.

Price Growth

GCTK (@Medical Specialties) experienced а +8.28% price change this week, while IVRO (@Medical Specialties) price change was -23.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.46%. For the same industry, the average monthly price growth was +1.12%, and the average quarterly price growth was -0.05%.

Reported Earning Dates

GCTK is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Medical Specialties (+4.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GCTK($8.11M) has a higher market cap than IVRO($912K). IVRO YTD gains are higher at: -15.385 vs. GCTK (-97.650).
GCTKIVROGCTK / IVRO
Capitalization8.11M912K889%
EBITDA-5.95MN/A-
Gain YTD-97.650-15.385635%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash6.89MN/A-
Total Debt184KN/A-
FUNDAMENTALS RATINGS
GCTK vs IVRO: Fundamental Ratings
GCTK
IVRO
OUTLOOK RATING
1..100
2687
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
1009
PRICE GROWTH RATING
1..100
6644
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
5047

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IVRO's Valuation (73) in the null industry is in the same range as GCTK (95). This means that IVRO’s stock grew similarly to GCTK’s over the last 12 months.

IVRO's Profit vs Risk Rating (96) in the null industry is in the same range as GCTK (100). This means that IVRO’s stock grew similarly to GCTK’s over the last 12 months.

IVRO's SMR Rating (9) in the null industry is significantly better than the same rating for GCTK (100). This means that IVRO’s stock grew significantly faster than GCTK’s over the last 12 months.

IVRO's Price Growth Rating (44) in the null industry is in the same range as GCTK (66). This means that IVRO’s stock grew similarly to GCTK’s over the last 12 months.

IVRO's P/E Growth Rating (95) in the null industry is in the same range as GCTK (100). This means that IVRO’s stock grew similarly to GCTK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GCTK
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
GCTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTNX70.912.21
+3.22%
Nutanix
HSCS3.48-0.03
-0.71%
HeartSciences Inc
DX12.19-0.14
-1.14%
Dynex Capital
BNL15.86-0.32
-1.98%
Broadstone Net Lease
NBTX3.31-0.08
-2.36%
Nanobiotix SA

GCTK and

Correlation & Price change

A.I.dvisor tells us that GCTK and QTRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GCTK and QTRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GCTK
1D Price
Change %
GCTK100%
+1.21%
QTRX - GCTK
32%
Poorly correlated
+0.17%
SIBN - GCTK
30%
Poorly correlated
+0.22%
OCX - GCTK
24%
Poorly correlated
+0.65%
INMD - GCTK
23%
Poorly correlated
+4.26%
PEN - GCTK
23%
Poorly correlated
-0.35%
More

IVRO and

Correlation & Price change

A.I.dvisor tells us that IVRO and ECIA have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVRO and ECIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVRO
1D Price
Change %
IVRO100%
-14.44%
ECIA - IVRO
20%
Poorly correlated
N/A
NMTC - IVRO
20%
Poorly correlated
-0.90%
IOBCF - IVRO
13%
Poorly correlated
-5.51%
KLYG - IVRO
9%
Poorly correlated
N/A
GCTK - IVRO
8%
Poorly correlated
+1.21%
More